Stage <scp>IIIA</scp> Non‐Small Cell Lung Cancer Treatment and Outcomes: A Single Institution Retrospective Analysis
In this single institution retrospective study, we find no significant differences in PFS, OS, and failure patterns between patients with Stage IIIA NSCLC treated with definitive (chemo)radiation and surgery with or without neoadjuvant therapy. Further work in the immunotherapy era is needed.
Authors
- Y. C. Liu
- C. Hu
- Jyoti Patel (ORCID: https://orcid.org/0000-0002-6919-5032)
- Michelle Kwan (ORCID: https://orcid.org/0000-0003-1983-5609)
- Poonam Yadav (ORCID: https://orcid.org/0000-0003-0558-9646)
- Nisheka N. Vanjani
- Richard Duan (ORCID: https://orcid.org/0000-0003-4098-262X)
- Avram Kordon
- Mohamed E. Abazeed (ORCID: https://orcid.org/0000-0002-6614-4440)
- Laila A. Gharzai (ORCID: https://orcid.org/0000-0001-6420-9274)
- Divya Gupta (ORCID: https://orcid.org/0009-0005-5173-3989)
- Zequn Sun (ORCID: https://orcid.org/0000-0003-4177-9199)
- Tarita O. Thomas
Institutions
- Northwestern University (US)
- Northwestern University (PH)
- Northwestern Medicine (US)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1111/1759-7714.70009
- Citations
- 1
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Northwestern University
- Feinberg School of Medicine
- Robert H. Lurie Comprehensive Cancer Center